EBBVI INK has a total of 29 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BEIJING SHENOGEN PHARMA GROUP LTD, BOEHRINGER INGELHEIM INTERNATIONAL GMBH and SERONO LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 29 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement | |
#6 | Medical technology | |
#7 | Engines, pumps and turbines | |
#8 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Organic chemistry methods | |
#8 | Syringes | |
#9 | Rotary-pistons | |
#10 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Uendt Majkl D | 5 |
#2 | Van Lu | 5 |
#3 | Tao Chzhi-Fu | 4 |
#4 | Frenk Kristin E | 4 |
#5 | Ardzhiriadi Mariya A | 4 |
#6 | Van Le | 4 |
#7 | Van Silu | 4 |
#8 | Uollejs Grir A | 4 |
#9 | Styuart Kent D | 3 |
#10 | Kanzer Aaron R | 3 |
Publication | Filing date | Title |
---|---|---|
RU2620351C2 | Automated injector | |
RU2605928C2 | Therapeutic dll4-binding proteins |